13F HOLDINGS REPORT
TCG Crossover Management, LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001214659-24-009128
Total Value
$1.26B
Positions
33
Other Managers
0
Confidential Omitted
No
Holdings (33)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CG ONCOLOGY, INC. | CGON | 3,570,206 | $156.7M | 12.39% |
| 2 | DYNE THERAPEUTICS, INC | DYN | 2,650,150 | $75.2M | 5.95% |
| 3 | ASTRIA THERAPEUTICS, INC. | 04635X102 | 5,278,928 | $74.3M | 5.87% |
| 4 | SILENCE THERAPEUTICS PLC | SLNCF | 3,295,350 | $71.2M | 5.63% |
| 5 | STRUCTURE THERAPEUTICS INC | GPCR | 1,598,421 | $68.5M | 5.42% |
| 6 | AEROVATE THERAPEUTICS INC | 008064107 | 2,201,274 | $65.1M | 5.15% |
| 7 | INHIBRX,INC | INBX | 1,750,387 | $61.2M | 4.84% |
| 8 | KEROS THERAPEUTICS, INC. | KROS | 879,344 | $58.2M | 4.60% |
| 9 | GERON CORP | GERN | 17,391,639 | $57.4M | 4.54% |
| 10 | SAVARA INC. | SVRA | 10,000,000 | $49.8M | 3.94% |
| 11 | OCULAR THERAPEUTIX, INC. | OCUL | 5,319,148 | $48.4M | 3.83% |
| 12 | COGENT BIOSCIENCES INC | COGT | 6,214,375 | $41.8M | 3.30% |
| 13 | EDGEWISE THERAPEUTICS, INC. | EWTX | 2,272,728 | $41.5M | 3.28% |
| 14 | MINERALYS THERAPEUTICS, INC. | MLYS | 3,185,185 | $41.1M | 3.25% |
| 15 | MADRIGAL PHARMACEUTICALS INC | MDGL | 149,283 | $39.9M | 3.15% |
| 16 | TOURMALINE BIO INC | 89157D105 | 1,477,593 | $33.8M | 2.68% |
| 17 | TYRA BIOSCIENCES INC | TYRA | 1,989,103 | $32.6M | 2.58% |
| 18 | COMPASS PATHWAYS PLC | CMPS | 3,858,000 | $32.1M | 2.54% |
| 19 | KURA ONCOLOGY INC | KURA | 1,423,642 | $30.4M | 2.40% |
| 20 | TARSUS PHARMACEUTICALS, INC. | TARS | 793,829 | $28.9M | 2.28% |
| 21 | ADVERUM BIOTECHNOLOGIES, INC. | 00773U108 | 2,008,340 | $28.4M | 2.25% |
| 22 | SOLENO THERAPEUTIVS, INC. | 834203200 | 550,000 | $23.5M | 1.86% |
| 23 | CENTESSA PHARMACEUTICALS PLC | CNTA | 2,040,816 | $23.1M | 1.82% |
| 24 | Abivax SA | AAVXF | 1,100,000 | $15.7M | 1.24% |
| 25 | VISTAGEN THERAPEUTICS INC | VTGN | 2,676,580 | $14.1M | 1.12% |
| 26 | KALVISTA PHARMACEUTICALS, INC | KALV | 1,163,356 | $13.8M | 1.09% |
| 27 | C4 THERAPEUTICS, INC. | CCCC | 1,276,574 | $10.4M | 0.82% |
| 28 | ENTRADA THERAPEUTICS INC | TRDA | 584,955 | $8.3M | 0.66% |
| 29 | AN2 Therapeutics, Inc. | ANTX | 1,555,118 | $5.1M | 0.40% |
| 30 | KODIAK SCIENCES INC | KOD | 899,999 | $4.7M | 0.37% |
| 31 | VENTYX BIOSCIENCES, INC | 92332V107 | 815,724 | $4.5M | 0.35% |
| 32 | NEKTAR THERAPEUTICS | NKTR | 4,000,000 | $3.7M | 0.30% |
| 33 | CABALETTA BIO, INC | CABA | 86,795 | $1.5M | 0.12% |